# Vertex Pharma Smashes Earnings, Highlights New Drugs

Page: https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/vertex-pharma-smashes-earnings-highlights-new-drugs
Text version: https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/vertex-pharma-smashes-earnings-highlights-new-drugs.md
Podcast: [Business News Today | 2 Min News | The Daily News Now!](https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192)
Published: 2026-05-14T01:14:31+00:00
Episode link: https://api.fastcast.ai/audio/1ce36f17-fcde-463f-b229-eea75a80692f.mp3
Audio file: https://api.fastcast.ai/audio/1ce36f17-fcde-463f-b229-eea75a80692f.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/business-finance-news-today-2-min-news-the-daily-news-now-7726192/episodes/vertex-pharma-smashes-earnings-highlights-new-drugs
Duration seconds: 107

## Resource

Vertex Pharmaceuticals exceeded expectations in Q1, with $2.99 billion revenue, a 7.8% year-over-year growth, and adjusted EPS of $4.47. Management attributed success to cystic fibrosis meds and new launches like KASJEVY and Gernavix. Operating margins surged to 38.1%. Analysts questioned Vertexs competitive edge and tolerability issues, prompting insights on Povi and cystic fibrosis treatments. Future focus includes KASJEVY and Gernavix adoption, povitacicepts regulatory push, and cystic fibrosis mods expansion. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/64ef4a08e2c2af0c

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/business-finance-news-today-2-min-news-the-daily-news-now-7726192/episodes/vertex-pharma-smashes-earnings-highlights-new-drugs/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/vertex-pharma-smashes-earnings-highlights-new-drugs.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.